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Oxidative stress plays an important role in the pathogenesis of falciparummalaria, a disease still claiming close to 1 million deaths
and 200 million new cases per year. Most frequent complications are severe anemia, cerebral malaria, and immunodepression, the
latter being constantly present in all forms of malaria. Complications are associated with oxidative stress and lipoperoxidation.
Its final product 4-hydroxynonenal (4-HNE), a stable yet very reactive and diffusible molecule, forms covalent conjugates with
proteins, DNA, and phospholipids and modulates important cell functions at very low concentrations. Since oxidative stress plays
important roles in the pathogenesis of severe malaria, it appears important to explore the role of 4-HNE in two important malaria
complications such as malaria anemia and malaria immunodepression where oxidative stress is considered to be involved. In this
review we will summarize data about 4-HNE chemistry, its biologically relevant chemical properties, and its role as regulator of
physiologic processes and as pathogenic factor. We will review studies documenting the role of 4-HNE in severe malaria with
emphasis on malaria anemia and immunodepression. Data from other diseases qualify 4-HNE both as oxidative stress marker and
as pathomechanistically importantmolecule. Further studies are needed to establish 4-HNE as accepted pathogenic factor in severe
malaria.
1. Introduction
In malaria pathophysiology, oxidative stress plays an impor-
tant role in many fatal endpoints of the disease [1, 2].
Imbalance in redox metabolism may be important under
two aspects. On the one hand, prooxidative reactions are
important in the host response to combat malaria infec-
tion in a controlled manner. Some protective mechanisms
againstmalaria, such as glucose-6-phosphate dehydrogenase-
(G6PD-) deficiency [3, 4] and hemoglobinopathies, were
proposed to be connected with oxidative stress (reviewed
in [1, 2]). Reactive nitrogen species were claimed to have
a protective role against blood-stage malaria [5]. However,
such protective role has been denied in other studies [6].
On the other hand, excess oxidative stress is harmful for
the host and may contribute to malaria complications with
potentially fatal outcome, such as severe malaria anemia and
immunodepression. Indications for excess lipoperoxidation
have been shown inmalaria, where plasma lipid peroxides are
increased [7] and red blood cells (RBCs) displayed increased
lipid peroxidation and decreased antioxidative defense [8, 9]
in clinical malaria.
Cellular dysfunctions following excess oxidative stress are
frequently mediated by lipoperoxidation products of nonen-
zymatic degradation of polyunsaturated fatty acids (PUFAs).
Lipid peroxidation progresses by free radical chain reactions
with lipid hydroperoxides as immediate unstable products
that decompose to a series of very reactive products. Among
these products, hydroxyaldehydes like 4-hydroxynonenal (4-
HNE) are particularly important because they reach relatively
high concentrations, are more stable as radicals, and are able
to diffuse inside or even outside the cell to reach distant
targets. Target molecules, with which 4-HNE forms covalent
conjugates, are proteins, DNA, and phospholipids [10, 11].
Thus, 4-HNE can be considered the final mediator and
marker of oxidative stress in cells and whole organisms.
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Figure 1: Omega-6 PUFAs are the source of 4-hydroxynonenal (4-
HNE).
The role of 4-HNE in malaria pathogenesis was recently
considered, and the malaria anemia is under special focus,
since 4-HNE was shown to play a pathomechanistic role in
this potentially deadly complication.
2. 4-HNE Chemistry (Generation, Biologically
Relevant Properties, and Metabolism)
4-HNE is the final product of two sequential processes: first
the generation of the hydroperoxide omega-6 polyunsatu-
rated fatty acid (PUFA) during lipid peroxidation and second
the carbon-chain break of the peroxidized PUFA together
with the introduction of a hydroxyl group. Only omega-6
PUFAs, such as the essential fatty acids linoleic acid and
arachidonic acid, play a role in 4-HNE generation (Figure 1).
Lipid peroxidation is a powerful nonenzymatic chain
reaction that continuously provides free lipid radicals for
further peroxidation. PUFAs are attacked by free radicals
regardless of whether the fatty acid is in free form (e.g., in the
circulation, noncovalently bound to albumin) or esterified in
phospholipids in the cellular membranes [12].
Thanks to their unpaired electron, free radicals are highly
reactive compounds. One of themost reactive representatives
of oxygen radicals is the hydroxyl radical (∙OH) that is able
to initiate the peroxidation process by hydrogen abstraction
from a C-atom positioned between two conjugated double
bonds in PUFAs (Figure 2). Similarly, iron (Fe2+/Fe3+) can
act as a catalyst for this step and produce additional hydroxyl
radicals.The result of hydrogen abstraction is a PUFA radical
which binds molecular oxygen, becoming highly reactive
peroxide that propagates the peroxidation chain reaction
by “stealing” hydrogen from a further PUFA to become
a PUFA hydroperoxide (PUFA-OOH). The newly formed
PUFA radical may continue the peroxidation chain reaction.
Similar to free iron, iron-containing heme is a highly efficient
catalyst and accelerates substantially the lipoperoxidation
process. The peroxidized PUFA rearranges the hydroperoxy
group within the molecule (Hock rearrangement [13]), and
the bond between carbons 9 and 10 of the fatty acid chain
is destabilized and breaks up. The so-called Hock cleavage
splits the peroxidized PUFA molecule between the C11 and
C12 carbon atoms (in case of arachidonic acid) and the
rearranged peroxy-group and releases the aldehyde nonenal
and the oxidized residual 11-C fatty acid. Nonenal consists
of the last 9 carbons of the omega-6 fatty acid. A further
peroxidation with hydrogen abstraction and oxygen binding
occurs at position 4 and the resulting 4-hydroperoxynonenal
is finally reduced to 4-HNE. All reactions may run efficiently
without enzyme catalysis and are enhanced by heme.
4-HNE is a 9 C-atom long aldehyde with a double bond
between the carbon atoms C2 and C3 conjugated to the
head aldehyde group (C1) and a hydroxyl group at the C4
position (Figure 2). While the aldehyde group is hydrophilic,
the nonpolar carbon chain from C5 to C9 is hydrophobic.
This explains the preferential enrichment of the molecule in
lipid-rich structures like membranes as well as the capacity
to cross the cell membrane. Thus, 4-HNE produced in a
cell is enriched intracellularly but is not confined to the
cell of origin but is found also extracellularly. 4-HNE was
described to interfere with membrane fluidity and phospho-
lipid asymmetry [14, 15]. The molecule is highly reactive due
to two reactive sites, the C3 carbon atom and the aldehyde
group. First, the conjugated system of C=C double bond
and C=O carbonyl group plus the hydroxyl group makes
the C3 atom more electropositive and thus susceptible to
nucleophilic attacks, which allow the formation of Michael
adducts with cysteine, histidine, and lysine residues, and
less frequently with arginine residues of polypeptide chains.
Second, the aldehyde group may react with free amino group
of lysine residues forming so-called Schiff bases frequently
seen in lipoproteins. Due to the presence of the two reactive
sites in 4-HNE mentioned before, high concentrations of
4-HNE can also cross-link two peptide chains (reviewed
in [16]). Further, 4-HNE was described to form adducts
with purine bases in DNA (4-HNE-deoxyguanosine). This
modification may play a role in tumor pathogenesis [17, 18].
The second nonprotein targets of 4-HNE-conjugation are
phosphatidylethanolamine and phosphatidylserine that react
with their free amino groups forming Michael adducts and
Schiff bases [19–21]. Also vitamin C (ascorbic acid) and
pyridoxamine, the precursor of vitamin B6, are targets for 4-
HNE-conjugation. Ascorbylation is assumed to play a role in
the elimination of 4-HNE from the body [22, 23].
In parallel, unconjugated 4-HNE is metabolized for
detoxification and better excretion. The main enzymes
involved in 4-HNEmetabolism are glutathione-S-transferase
(GSTA4-4, EC 2.5.1.18) that catalyzes the synthesis of the
4-HNE-GSH adducts, aldehyde reductase (EC 1.1.1.21) that
oxidizes 4-HNE to hydroxynonenoic acid (HNA), and alco-
hol dehydrogenase (EC 1.1.1.1) that reduces 4-HNE to 1,4-
dihydroxynonene (DHN) [24, 25].
Proteins modified by 4-HNE are degraded by the pro-
teasome in the cell cytosol but accumulate in case of high
oxidative stress and may contribute to functional losses [26].
3. 4-HNE Role in Health and Disease
3.1. Cellular Targets of 4-HNE and Its Potential Functional
Importance. The concentrations of 4-HNE detectable in
human serum under nonpathological conditions are 0.05–
0.15 micromoles per liter, increasing with age. Kidney tubular
cells, hepatocytes, and monocytes revealed higher tissue
concentrations (between 1 and 100 micromoles per liter)
varying by tissue type and organism condition (for review
see [10, 27]). Although it seems unlikely that overall con-
centration may reach 100 micromoles per liter in organs,
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Figure 2:The formation of 4-HNE from arachidonic acid by lipid peroxidation, chain break, and hydroxylation. Inmalaria, it was shown that
the heme core of hemozoin (HZ, malaria pigment) could catalyze the lipoperoxidation of PUFAs. Resulting hydroperoxides are chemically
unstable: they (i) are reduced to the hydroxy-fatty acid such as hydroxyeicosatetraenoic acid (HETE) from arachidonic (note, HETEs are
bioactive PPAR-𝛾 (peroxisome proliferator-activated receptor gamma) ligands) or (ii) are decomposed to 4-HNE. C1 and C3 are 4-HNE
reactive sites. Biologically relevant properties of 4-HNE are listed in blue.
it is plausible that such levels may build up locally near
peroxidized membranes. 4-HNE was calculated to reach 4
millimoles per liter in microsomes. Due to cumulative effect
in the membrane, 4-HNE may attack critical target proteins
in or near the lipid bilayer. Accordingly, monocytes where the
enzyme NADPH-oxidase produces oxygen radicals directed
against extracellular and intracellular microbes during the
oxidative burst reaction may contain 40 micromoles per liter
or higher 4-HNE concentrations [28, 29]. At low concentra-
tion, 4-HNE is considered an efficient signaling molecule,
whilst under oxidative stress the metabolism of 4-HNE may
be saturated and modifications of biomolecules may elicit
pathological effects. Proteinmodifications represent themain
knownmechanism by which 4-HNE influences physiological
and pathological processes.
A high and increasing number of 4-HNE target proteins
have been identified. The binding sites of 4-HNE to the pro-
tein chain were determined by mass spectrometry for about
half of the proteins functionally modified by 4-HNE. The
functional annotation of the structurally and/or functionally
modified proteins covers a wide spectrum including enzymes
in energy metabolism, protein kinases and phospholipases
involved in cellular signaling, enzymes involved in intracellu-
lar proteolysis by the proteasome, extracellular matrix metal-
loproteinases, membrane receptors for neurotransmitter and
growth factors, membrane ion transporter and carriers in
the plasma membrane, some plasma proteins, cytoskeletal
proteins, heat-shock proteins, and proteins involved in trans-
lation [10, 27, 30–35].
3.2. Regulation of Physiological Processes. The cellular
increase of 4-HNE in response to oxidative stress can
potently activate stress response mechanisms. Nontoxic
levels of 4-HNE have been described to modify (i) signal
transduction regulating the de novo synthesis of detoxifying
enzymes (e.g., via transcription factor Nrf2 and the
transcription-enhancer antioxidant response element ARE);
(ii) cell proliferation (e.g., via c-Jun N-terminal kinase JNK);
(iii) apoptosis and cell cycle regulation (e.g., via p53); (iv)
differentiation (e.g., via mitogen-activated protein kinase
MAPK and growth factor receptors); (v) inflammatory
response; (vi) expression of the cellular adhesion molecules
ICAM-1, VCAM-1, and E-selectin (e.g., via transcription
factors p38 and NF-kappaB); and (vii) protein turnover (via
proteasome activity) [10, 11, 36–38]. Modification of these
pathways may be associated with survival mechanisms of
cells or tissues under stress condition.
3.3. Association of 4-HNE with Pathologies. Uncontrolled or
excessive production of 4-HNE could interfere with basal
cellular signaling and play a role in the pathogenesis of several
diseases accompanied by oxidative stress. In 39 different
human diseases increased steady-state levels of 4-HNE have
been either reported in the affected organ or generalized
in the blood plasma or both [10, 39] which suggests a
pathogenic role of the aldehyde in the disease pattern and
progression. It is now accepted that 4-HNE plays a role in
inflammation-related cell signaling. Importantly, inflamma-
tion represents the main driving force in progression of most
4 Oxidative Medicine and Cellular Longevity
Systemic host oxidative stress
Contact between monocytes and RB/nHZ 
(brown arrows) triggers oxidative burst and 
peroxidation
O
OH
O
O
O
OH
OH
OH
O
O
O
OH
OH
OH
4-HNE shedding
from growing trophozoites and schizonts
4-HNE shedding from HZ-containing residual
body (RB, brown arrow) after release in the
bloodstream after schizogony
HZ-fed monocytes in blood and macrophages in
tissues release 4-HNE for long periods of time
Figure 3: 4-HNE source in malaria.
chronic diseases, in acute inflammatory diseases and in some
anemias, as renal anemia [40].
4. 4-HNE Production in Malaria
4-HNE has received little attention by malariologists as yet,
although elevated levels of free, unconjugated 4-HNE had
been described in RBCs of P. vinckei-infected mice as early as
1988 [41]; one study reported the growth inhibition of in vitro
cultured parasites by 4-HNE [42], and the general presence
of oxidative stress in malaria was detected long ago [43–46].
4.1. 4-HNE from the Parasite. During its development
the malaria parasite digests the major part of host RBC
hemoglobin and polymerizes the undigested and prooxidant
heme to HZ (hemozoin, malaria pigment) in close contact
with the membrane of the digestive vacuole of the parasite
[47]. Similar to free heme, isolated HZ catalyzes in vitro the
peroxidation of PUFAs with subsequent degradation to 4-
HNE and other products (Figures 1 and 2 and [48]). The
onset of hemoglobin degradation andHZ formation at young
trophozoite stage coincidedwith a significantly enhanced for-
mation of 4-HNE and 4-HNE-membrane protein conjugates
in parasitized RBCs, compared to nonparasitized control
RBCs.The progressive HZ generation during parasite growth
was accompanied by the increase of 4-HNE conjugates up
to 15-fold higher levels in HZ-rich schizonts compared to
young HZ-free ring-forms (Figure 3). The conjugates can be
detected and quantified by flow cytometry or fluorescence
microscopy after recognition by specific antibodies [11, 49,
50]. 4-HNE conjugates are not confined to 4-HNE-producing
cells but were also found in nonparasitized RBCs (npRBCs)
cytoadherent to trophozoites (see Figure 4) [51].
4.2. 4-HNE from the Residual Body. The synthetic beta-
hematin core of natural HZ (nHZ) is able to catalyze in
vitro the PUFA peroxidation with formation of 4-HNE
and hydroxy-fatty acids such as hydroxylated arachidonic
acid (hydroxyeicosatetraenoic acid, HETE) or hydroxy-
lated linoleic acid (hydroxyoctadecadienoic acid, HODE)
(Figure 2, [48]). At the end of the 48 h parasite growth cycle
in the RBC, the daughter parasites leave the RBC to infect
fresh RBCs (schizogony). In parallel the residual body (RB)
or nHZ, that is, the membrane-enveloped, HZ-containing
digestive vacuole, is expelled into the bloodstream. The RBs
collected from culture supernatant contained 50 micromoles
per liter of free 4-HNE (Figure 3, [52]), which was released
and transferred to adjacent cells in an in vitro erythropoiesis
model (Figure 5). Hence, RBs represent an additional source
of 4-HNE in pathology [52].
4.3. 4-HNE from Human Phagocytes. RBs released into
plasma bind preferentially host fibrinogen and to a lesser
extent immunoglobulins (IgGs) and complement factors.
Fibrinogen was constantly present at 10–100,000 fibrinogen
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Figure 4: 4-HNE transfer from parasitized to nonparasitized RBCs
in rosettes in vitro. Micrographs of 4-HNE-positive parasitized
RBCs and nonparasitized RBCs.This result was originally published
in British Journal of Haematology, Blackwell Publishing Ltd. (Uyoga
et al. 2012, © John Wiley & Sons Ltd.).
molecules per residual body and was stably bound to
nHZ collected from plasma-cultured parasites [53]. Surface-
binding changes the conformation of fibrinogen andmakes it
recognizable by Toll-like receptor 4 (TLR4) on monocytes.
RBs coated with fibrinogen become excellent ligands for
TLR4 and were responsible for the rapid 100-fold stronger
production of reactive oxygen species by human mono-
cytes [53]. Close contact of HZ with the cell membrane,
together with extensive oxidative burst during HZ phagocy-
tosis, resulted in fast and persistent 6-fold increase of lipid
peroxides in RB-fed monocytes compared to the transient
2-fold increase after RBC phagocytosis [54]. 4-HNE was
significantly increased at 2 h after feedingmonocyteswithHZ
and peaked at 5 h attaining 50-fold levels compared to unfed
controls and was still almost 15-fold the control levels after
12 h [28]. The long-lasting generation of 4-HNE (Figure 3)
is caused by a persisting lipoperoxidation catalyzed by HZ
after its uptake into the lysosome of the monocytes. The
generation of 4-HNE in HZ-fed monocytes is followed by
a significant increase of 4-HNE conjugate formation with
membrane proteins [52].
In summary, HZ can be considered to be source and
shuttle for 4-HNE in malaria and 4-HNE is likely one
molecular mediator of the HZ effects (reviewed in [55, 56]).
5. 4-HNE Effect on Immune Response
and Malaria Anemia
HZ or RB has been described to interfere with several
immune processes that might play a role in malaria and
contribute to the lack of sterile immunity as well as in
complicated forms of malaria [56]. As described above, HZ
acts as catalyst and shuttle for 4-HNE in malaria. Thus, a
series of HZ effects were recapitulated by exogenously added
4-HNE, and molecular targets for 4-HNE listed above were
modified by 4-HNE in HZ-fed cells. The roles of 4-HNE on
the pathophysiologically relevant processes are listed below.
5.1. Phagocytosis, Oxidative Burst, and MHC Class II Expres-
sion: Protein Kinase C (PKC) Involvement. Phagocytosis and
oxidative burst are first-line defense mechanisms against the
blood-stage malaria parasite. After avid phagocytosis of HZ
and a violent oxidative burst elicited by mature parasites
and released RB, both phagocytosis and burst are switched
off after approximately 6–12 h from initial phagocytosis and
remain inactive during the observation period of 3 days [54].
Phagocytes do not die and do not show signs of apoptosis
[54, 57] that could explain the inactivation. Inmalaria disease
large proportions of resident macrophages and circulating
monocytes and neutrophils contain massive amounts of HZ.
When fed with HZ in vitro, the precursors of macrophages,
the monocytes, lose their capacity to upregulate the antigen
presenting MHC class II in response to interferon-gamma
suggesting thatHZ loadingmay contribute to the impairment
of the immune response and derangement of antigen presen-
tation previously reported in falciparummalaria [56, 58].
Protein kinase C (PKC), the common regulator protein
that coordinates phagocytosis, burst, and antigen presenta-
tion, was shown to be inactivated by 4-HNE-conjugation
in vitro, and HZ-fed monocytes exhibited a high level of
4-HNE-conjugated PKC [28]. The kinetics of 4-HNE pro-
duction and conjugate formation after HZ phagocytosis fit
with the quick loss of active membrane-associated PKC and
the subsequent disappearing responsiveness of cytosolic PKC
to activators in HZ-fed monocytes [59]. Thus, we consider
4-HNE to be a molecular mediator in the HZ-provoked
modulation of immune responses such as inhibition of
oxidative burst, phagocytosis, and antigen presentation by
MHC class II.
Comparison of transcriptional changes elicited by syn-
thetic HZ and 4-HNE in murine macrophages suggests
that both are involved in the modulation of inflammatory
responses, transcription factor NF-kappaB-dependent signal
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transduction, and extracellular matrix degradation [60] fur-
ther confirming 4-HNE as an immune-modulating factor of
interest in malaria.
5.2. Dendritic Cell Differentiation andMaturation. Enhanced
4-HNE production and formation of membrane protein-4-
HNE conjugates were observed inHZ-fedmonocytes in their
differentiation towards DC [52]. Functionally, phagocytosis
of HZ-containing parasites or HZ by itself (HZ is here
synonymous with RBs), as well as 4-HNE and/or HETE
generated and carried by HZ, inhibited the differentiation
andmaturation ofDC [57]. In particular, 4-HNE significantly
inhibited the expression of CD83, the functionally important
marker for mature DCs, mimicking the effect of HZ or
HETE [56, 57].Moreover, 4-HNEdose dependently inhibited
the expression of CD83 in differentiating DCs [52] and 4-
HNE added at reasonably low doses significantly inhibited
the protein expression of MHC classes I and II, CD1a,
and accessory molecules, which can modulate the ability of
immune cells to develop or perform their functions [61],
such as CD40, CD54, and CD83 [57]. Additionally, 4-HNE
modified the responsiveness of GM-CSF receptor, the crucial
growth factor for dendritic cell differentiation in vitro [52].
Similar to phagocytosis of HZ, the addition of 4-HNE
resulted in increased expression of the nuclear receptor
PPAR-gamma (peroxisome proliferator-activated receptor
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gamma) in the immune cells [36, 57]. After activation (e.g.,
by HETE) PPAR-gamma moves into the nucleus where
it regulates immune cell functions [62] and functionally
suppresses the transcription factor NF-kappaB [63]. NF-
kappaB controls proinflammatory immune responses [64],
DC differentiation, DC maturation, and CD83 expression
related to the latter process.
5.3. Cell Cycle Control and Membrane Receptor Expression in
Erythropoiesis. Dyserythropoiesis (defective production of
RBC) is an important determinant of severe malaria anemia.
Erythropoiesis prominently occurs in the bone marrow ery-
throblastic islands, microenvironmental niches in which ery-
throid progenitors proliferate, differentiate, and finally expel
their nucleus at the end of the maturation process. An island
is formed by a central macrophage surrounded by developing
and differentiating erythroid cells from early stages through
reticulocytes [65]. Marrow macrophages and erythroid pre-
cursors have been shown to contain HZ in malaria patients
[66, 67]. 4-HNE, the production of which is enhanced byHZ,
was first shown to interfere with erythropoiesis in an in vitro
model of the initial stages of erythroid development in the
bone marrow [68]. Both supplemented free 4-HNE and 4-
HNE contained in HZ supernatants inhibited erythroid cell
colony growth. Application of advanced cell culture protocols
allows the complete differentiation of umbilical cord blood-
derived erythroid stem cells to fully mature enucleated
RBCs and to analyze biochemical parameters crucial for this
proliferation-dependent differentiation program. Erythroid
stem cells incubated with 4-HNE displayed sustained high
levels of 4-HNE-protein conjugate on their surface [69].
Human phagocytes either HZ-laden or cocultured with HZ
were able to shed 4-HNE that diffused to the surrounding
erythroid cells and was detected on the surface of those
cells as 4-HNE-protein conjugate (Figure 5). 4-HNE inhibits
the erythroid cell proliferation during the whole period of
erythropoiesis, involving the molecular regulators of the
cell cycle, a series of controlled events that take place in
a cell leading to its division [69]. Both natural HZ and 4-
HNE treatment of erythroid cells results in (i) increased
regulatory proteins: p53 (tumor suppressor protein 53) and
p21 (cyclin-dependent kinase inhibitor 1); (ii) unbalanced
phosphorylation of the retinoblastoma protein Rb; (iii)
decreased levels of cyclins A and D. Importantly, neither
HZ nor 4-HNE added at reasonable concentrations induced
programmed cell death (apoptosis). Further, lowmicromolar
4-HNE delays the differentiation marker expression: the
functionally important membrane receptors for transferrin
(TfR1, CD71), stem cell factor c-kit (CD117), interleukin-3
(CD123), and erythropoietin (EpoR) as well as the stem cell
marker CD34, and the RBC markers glycophorin A and
hemoglobin. GATA-1, the master transcription factor that
controls the differentiation processes in erythropoiesis, was
less expressed in HZ- and 4-HNE-treated cells. The impaired
cell cycle and reduced receptor expression decreased the total
cell yield and specifically the yield of differentiated erythroid
cells [69]. These results reconfirm the inhibitory role of
HZ, identify 4-HNE as HZ-generated inhibitory molecule
for proliferation and differentiation, and describe molecular
targets of 4-HNE in erythroid progenitors possibly involved
in the inhibition of erythropoiesis in malaria anemia.
5.4. RBC Membrane Proteins and Phagocytosis. Excessive
loss of npRBC, in addition to impaired erythropoiesis, is
considered to be cause for malaria anemia. Parasitized RBCs
generate 4-HNE that conjugates with membrane skeleton
proteins such as spectrin and actin and the integral mem-
brane protein band 3 [51, 70] that contributes to anchoring
the cytoskeleton to themembrane. 4-HNE-conjugation is not
confined to the parasitized RBCs but 4-HNE is transferred
and binds to adjacent npRBCs as shown in Figure 4where the
central trophozoite-infected RBC is surrounded by npRBCs
[51]. The differential labeling of pRBCs and npRBCs with a
nuclear fluorescent probe (e.g., ethidium bromide) allows the
separate analysis by flow cytometry of membrane protein-4-
HNE conjugates in both cell cohorts [51]. Similar to npRBCs,
protein-4-HNE conjugates are detectable in 4-HNE-treated
RBCs causing loss in deformability and increased phagocy-
tosis [51]. As decreased deformability and increased phago-
cytosis add to RBC elimination in the spleen, 4-HNE is
suggested to be instrumental for the removal of large numbers
of npRBCs.
5.5. Cytoskeleton Modifications and Impairment of Chemo-
tactic Motility and Transendothelial Migration of Monocytes.
Immune cell motility is an important physiological pro-
cess, relatively poorly studied in malaria. Recently it was
shown that nHZ phagocytosis by human primary monocytes
impaired their chemotacticmotility towardMCP-1, TNF, and
FMLP and their diapedesis across a confluent endothelial
cell layer toward MCP-1 [71]. No inhibition was detected in
control latex-fed or unfed monocytes. Microscopic analysis
has shown that the polarization defect in nHZ-fed mono-
cytes was due to irregular actin polymerization. Similar to
nHZ phagocytosis, the exposure of monocytes to in vivo-
compatible 4-HNE concentrations inhibited cell motility in
both the presence and the absence of chemotactic stimuli,
suggesting the impairment of cytoskeleton dynamics. Conse-
quently, 4-HNE conjugates with the cytoskeleton proteins 𝛽-
actin and coronin-1A were identified in nHZ-fed monocytes
and localized in domains of protein-protein interactions
involved in cytoskeleton reorganization and cell motility.The
molecular and functional modifications of actin and coronin
by nHZ/4-HNE may also explain impaired phagocytosis,
another motility-dependent process previously described in
nHZ-fed monocytes [54]. This study indicates that impaired
monocyte motility may contribute to the immune depres-
sion and the frequent occurrence of secondary infections
observed in malaria patients [71].
Figure 6 summarizes molecules and processes of poten-
tial relevance for malaria pathology that were structurally or
functionally modified by 4-HNE.
6. 4-HNE in Clinical Malaria and in
Malaria Anemia
In vitro and clinical data strongly indicate that oxidative
stress plays important roles in falciparum malaria, notably
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Figure 6: Proteins and processes of potential relevance for malaria pathology structurally or functionally modified by 4-HNE.
in the pathogenesis of severe anemia. However, oxidative
modifications of the RBC membrane by 4-HNE, which may
mechanistically clarify the pathogenesis of clinical malaria
as described above, have not been tested for their clinical
significance until recent times.
Two important clinical trials, performed from 2005 to
2011 in malaria endemic regions of Mozambique [9] and
Kenya [51], have shown that increased 4-HNE generation
is occurring in clinical malaria. Small cohorts with mild to
severe anemia have been studied to see whether a correlation
between 4-HNE-conjugation and anemia was present.
6.1. Elevated 4-HNE Conjugates in Clinical Malaria.
Oxidative stress markers including 4-HNE conjugates
in RBC membranes and advanced oxidation protein
products (AOPP) were longitudinally assessed in a large
cohort of nonimmune Mozambican newborns. The study
was performed in the period from 2.5 to 24 months of age,
and additionally at the first clinical malaria episode and in
convalescence, and included analysis of association with
the malaria incidence rate until 2 years of age [9]. A large
data base for control values and values in clinical malaria of
the same cohort of very young children allows defining the
influence of clinical disease on 4-HNE generation: (i) 4-HNE
conjugates significantly increased by approximately 75% in
parasitized and nonparasitized RBCs during clinical malaria;
(ii) 4-HNE conjugates correlated with plasma but not with
RBC oxidative stress markers during clinical malaria; (iii)
in contrast to plasma oxidative stress markers, 4-HNE
conjugates remained significantly elevated in convalescence
after clearing of malaria parasites from peripheral blood in
comparison to the healthy state before clinical malaria; and
(iv) high levels of 4-HNE conjugates in individual healthy
children were predictive of increased malaria incidence rates
until 2 years of age [9]. Above data underscore the clinical
significance of 4-HNE in malaria immunology and the
potential role of 4-HNE for impaired immune functions of
phagocytes as described in Sections 5.1 and 5.2.
6.2. Role of 4-HNE in Malaria Anemia. As outlined before,
4-HNE demonstrated a strong inhibitory effect on ex vivo
erythropoiesis of human erythroid stem cells, also contribut-
ing to enhanced phagocytosis of RBCs in vitro. Both ery-
thropoiesis inhibition and enhanced phagocytosis of npRBCs
were shown to contribute to severe malaria anemia. First
indications for the clinical relevance of 4-HNE as amolecular
pathogenic factor for malaria anemia come from studies in
Mozambique and Kenya mentioned before [9, 51]. Elevated
or increasing 4-HNE conjugate levels in convalescence were
associated with sustained anemia or aggravated anemia
during convalescence (Figure 7, [5]). Children with severe
malaria anemia had significantly higher percentages of 4-
HNE-conjugate-positive npRBCs compared to children with
uncomplicated malaria [51]. In conclusion, 4-HNE is sug-
gested to play a role in the phagocytic removal of npRBCs,
one hallmark of severe malaria anemia.
Of note, field studies have shown that another blood
oxidative stress marker, the advanced oxidative protein prod-
ucts (AOPP), has been shown to be predictive of malaria
anemia [72].This data, together with the correlation between
AOPP and 4-HNE conjugates level on RBC established in
clinical malaria [9], will strengthen the role of increased 4-
HNE levels as part of systemic oxidative stress.
7. Conclusions
Results of studies summarized in this review indicate that 4-
HNE is a highly active molecule produced by the malaria
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Figure 7: Association of 4-HNE conjugate levels on RBCs with sustained moderate anemia during convalescence. Children presenting with
Hb < 100 g/L at their first acute malaria episode were grouped according to their capacity to recover from anemia by increasing Hb levels
during convalescence or to worsen their state by decreasing or sustained low Hb levels during convalescence (1 month after acute malaria
episode). 4-HNE binding to the RBCs of children was assessed as MFI at acute and convalescence states. Mean MFI-values ± SE during
convalescence are plotted for the groups with increasing Hb (+35,3± 6,5%;𝑁 = 34) and decreasing Hb (−15,4± 6,0%;𝑁 = 8) (a).The change
in 4-HNE conjugate levels in the RBC membrane during recovery from malaria disease is shown (b). The mean ± SE of the ratio of 4-HNE
conjugatesmeasured during convalescence and at acute state is plotted for the increasing (+38,5±9,2%;𝑁 = 22) and decreasing (−26,8±6,2%;
𝑁 = 4) Hb groups, respectively (b). The significance of differences between groups is indicated by ∗ when 𝑃 < 0.05. MFI, mean fluorescence
intensity; Hb, hemoglobin. This result was originally published in British Journal of Haematology, Blackwell Publishing Ltd. (Aguilar et al.
2014, © John Wiley & Sons Ltd.).
parasite and by the host immune system in response to
infection. In ex vivo cell cultures 4-HNE was found to
impair several immune functions of phagocytic cells that
certainly contribute to malaria pathology. Similarly, 4-HNE
was found to impair the development of mature RBCs and
to enhance their elimination by the spleen leading to anemia.
Clinically,malaria disease is accompanied by elevated 4-HNE
levels. Clinical studies indicate that 4-HNE is involved in the
pathogenesis of malaria anemia. However, despite abundant
evidence from current research, further clinical studies are
necessary to better establish this promising molecule as an
accepted pathogenic factor in severe malaria.
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